Plasma biomarkers of Alzheimer’s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations
Plasma biomarkers of amyloid, tau and neurodegeneration (ATN) need to be characterized in cognitively unimpaired (CU) elderly individuals. Here, the authors show plasma ATN biomarkers predict clinical deterioration and cognitive decline and show in a simulated clinical trial combining all three biom...
Enregistré dans:
Auteurs principaux: | Nicholas C. Cullen, Antoine Leuzy, Shorena Janelidze, Sebastian Palmqvist, Anna L. Svenningsson, Erik Stomrud, Jeffrey L. Dage, Niklas Mattsson-Carlgren, Oskar Hansson |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ed33539191794e8abd8ebdc03d75b61a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer’s disease
par: Atul Kumar, et autres
Publié: (2021) -
Accelerated inflammatory aging in Alzheimer’s disease and its relation to amyloid, tau, and cognition
par: Nicholas C. Cullen, et autres
Publié: (2021) -
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
par: Niklas Mattsson-Carlgren, et autres
Publié: (2021) -
Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies
par: Niklas Mattsson-Carlgren, et autres
Publié: (2020) -
Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease
par: Shorena Janelidze, et autres
Publié: (2020)